Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
- PMID: 7508683
- PMCID: PMC1887146
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
Abstract
The plexiform lesion in primary pulmonary hypertension is a glomeruloid structure forming channels in branches of the pulmonary artery. These lesions have been considered an abnormal growth of modified smooth muscle cells. We present immunohistochemical evidence in 10 cases of plexogenic pulmonary hypertension that the plexiform channels and the concentric obliterative arteriopathy associated with these channels represent abnormal growth of factor VIII-related antigen-positive endothelial cells. In addition, these cells strongly expressed vimentin, a growth- and differentiation-related intermediate filament. Morphologically and immunohistochemically, the lesions resembled the neovascularization associated with the brain tumor glioblastoma multiform. Furthermore, we noted an exclusively perivascular inflammatory cell infiltrate (but no vasculitis) in seven of the 10 cases with plexogenic arteriopathy composed of T cells, B cells, and macrophages. Our findings indicate that the plexiform lesion may result from a deregulated growth of endothelial cells. The presence of perivascular inflammatory cells suggested that cytokines and growth factors may further influence the development of the plexiform lesion.
Comment in
-
Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion.Am J Pathol. 2001 Jul;159(1):382-3. doi: 10.1016/S0002-9440(10)61705-1. Am J Pathol. 2001. PMID: 11438486 Free PMC article. No abstract available.
Similar articles
-
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.J Pathol. 2001 Oct;195(3):367-74. doi: 10.1002/path.953. J Pathol. 2001. PMID: 11673836
-
Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.Vascul Pharmacol. 2008 Oct-Dec;49(4-6):113-8. doi: 10.1016/j.vph.2008.06.003. Epub 2008 Jun 20. Vascul Pharmacol. 2008. PMID: 18606248 Review.
-
CD44 expression in plexiform lesions of idiopathic pulmonary arterial hypertension.Pathol Int. 2012 Apr;62(4):219-25. doi: 10.1111/j.1440-1827.2011.02779.x. Epub 2012 Jan 10. Pathol Int. 2012. PMID: 22449225
-
Plexiform lesions in the lungs of domestic fowl selected for susceptibility to pulmonary arterial hypertension: incidence and histology.Anat Rec (Hoboken). 2011 May;294(5):739-55. doi: 10.1002/ar.21369. Epub 2011 Mar 29. Anat Rec (Hoboken). 2011. PMID: 21448992
-
Pulmonary hypertension in autoimmune rheumatic diseases.Autoimmun Rev. 2004 Jun;3(4):313-20. doi: 10.1016/j.autrev.2003.11.004. Autoimmun Rev. 2004. PMID: 15246028 Review.
Cited by
-
Lung Circulation.Compr Physiol. 2016 Mar 15;6(2):897-943. doi: 10.1002/cphy.c140049. Compr Physiol. 2016. PMID: 27065170 Free PMC article. Review.
-
Inflammatory markers are elevated in Eisenmenger syndrome.Pediatr Cardiol. 2013;34(8):1791-6. doi: 10.1007/s00246-013-0715-3. Epub 2013 May 11. Pediatr Cardiol. 2013. PMID: 23666048
-
Roles of LncRNAs in the Pathogenesis of Pulmonary Hypertension.Rev Cardiovasc Med. 2024 Jun 17;25(6):217. doi: 10.31083/j.rcm2506217. eCollection 2024 Jun. Rev Cardiovasc Med. 2024. PMID: 39076325 Free PMC article. Review.
-
Reactive oxygen species in pulmonary vascular remodeling.Compr Physiol. 2013 Jul;3(3):1011-34. doi: 10.1002/cphy.c120024. Compr Physiol. 2013. PMID: 23897679 Free PMC article. Review.
-
Symptom phenotypes in pulmonary arterial hypertension: The PAH "symptome".Pulm Circ. 2022 Jul 1;12(3):e12135. doi: 10.1002/pul2.12135. eCollection 2022 Jul. Pulm Circ. 2022. PMID: 36186717 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical